Renes Betula Special Order

Manufacturer: Uriel Pharmacy Inc.
Effective date: 2018-06-06
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-06-01 02:10:16

Label at a glance#

ProductRenes Betula Special Order

Active ingredientELYMUS REPENS TOP, ONONIS REPENS ROOT, PARSLEY, CAPSELLA BURSA-PASTORIS, ARCTOSTAPHYLOS UVA-URSI LEAF, SOLIDAGO VIRGAUREA FLOWERING TOP, BETULA PUBESCENS LEAF, EQUISETUM ARVENSE TOP, CYTISUS SCOPARIUS FLOWERING TOP, PORK KIDNEY, COPPER

Label structure9 sections

Contacts and useful links#

PhoneLabel contact866.642.2858

Websitewww.urielpharmacy.com

www.urielpharmacy.com

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Directions: FOR ORAL USE ONLY.

DOSAGE & ADMINISTRATION SECTION

Dissolve pellets under the tongue 3-4 times daily. Ages 12 and older: 10 pellets. Ages 2-11: 5 pellets. Under age 2: Consult a doctor.

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients: Agropyrum e. rad. (Couch grass) 2X, Ononidis (Moth) 2X, Petroselinium (Parsley herb) 2X, Petroselinium (Parsley root) 2X, Solidago (Goldenrod) 2X, Capsella bursa pastoris (Shepherd’s purse) 2X, Uva ursi (Bearberry) 2X, Betula (Silver birch leaves) 3X, Equisetum (Common horsetail) 3X, Sarothamnus (Broom) 3X, Renes (Bovine kidneys) 4X, Cuprum met. (Copper) 8X

INACTIVE INGREDIENT SECTION

Inactive Ingredient: Sucrose

OTC - PURPOSE SECTION

Use: Temporary relief of urinary discomfort.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

WARNINGS SECTION

Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Contains sugar. Diabetics and persons intolerant of sucrose (sugar): Consult a doctor before use. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.

OTC - QUESTIONS SECTION

Questions? Call 866.642.2858 Uriel, East Troy, WI 53120 www.urielpharmacy.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RenesBetulaSOPellets

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c599c4a0-705d-4ebb-ab1f-977af038f96a	Product name	1	20251124

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
48951-8235-2	Renes Betula Special Order	1350 in 1 BOTTLE, GLASS	PELLET	1350		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
48951-8235	RENES BETULA SPECIAL ORDER PELLET [URIEL PHARMACY INC.]	3	Legacy NDC, 1 package rows	20180606_bf43d998-18c6-4fd7-ac6a-b452fe02fbac.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ARCTOSTAPHYLOS UVA-URSI LEAF	ACTIVE INGREDIENT	3M5V3D1X36	1
BETULA PUBESCENS LEAF	ACTIVE INGREDIENT	84SOH0O3OO	1
CAPSELLA BURSA-PASTORIS	ACTIVE INGREDIENT	W0X9457M59	1
COPPER	ACTIVE INGREDIENT	789U1901C5	1
CYTISUS SCOPARIUS FLOWERING TOP	ACTIVE INGREDIENT	XZC6H8R666	1
ELYMUS REPENS TOP	ACTIVE INGREDIENT	8K1MK5E1FY	1
EQUISETUM ARVENSE TOP	ACTIVE INGREDIENT	1DP6Y6B65Z	1
ONONIS REPENS ROOT	ACTIVE INGREDIENT	W06YCM9T44	1
PARSLEY	ACTIVE INGREDIENT	58FMD0Q0EV	1
PORK KIDNEY	ACTIVE INGREDIENT	X7BCI5P86H	1
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE INGREDIENT	5405K23S50	1
ARCTOSTAPHYLOS UVA-URSI LEAF	ACTIVE MOIETY	3M5V3D1X36	1
BETULA PUBESCENS LEAF	ACTIVE MOIETY	84SOH0O3OO	1
CAPSELLA BURSA-PASTORIS	ACTIVE MOIETY	W0X9457M59	1
COPPER	ACTIVE MOIETY	789U1901C5	1
CYTISUS SCOPARIUS FLOWERING TOP	ACTIVE MOIETY	XZC6H8R666	1
ELYMUS REPENS TOP	ACTIVE MOIETY	8K1MK5E1FY	1
EQUISETUM ARVENSE TOP	ACTIVE MOIETY	1DP6Y6B65Z	1
ONONIS REPENS ROOT	ACTIVE MOIETY	W06YCM9T44	1
PARSLEY	ACTIVE MOIETY	58FMD0Q0EV	1
PORK KIDNEY	ACTIVE MOIETY	X7BCI5P86H	1
SOLIDAGO VIRGAUREA FLOWERING TOP	ACTIVE MOIETY	5405K23S50	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Renes Betula Special Order
SUCROSE
ELYMUS REPENS TOP
ONONIS REPENS ROOT
PARSLEY
CAPSELLA BURSA-PASTORIS
ARCTOSTAPHYLOS UVA-URSI LEAF
SOLIDAGO VIRGAUREA FLOWERING TOP
BETULA PUBESCENS LEAF
EQUISETUM ARVENSE TOP
CYTISUS SCOPARIUS FLOWERING TOP
PORK KIDNEY
COPPER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
48951-8235	48951-8235-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
ELYMUS REPENS TOP	8K1MK5E1FY	ACTIB
ONONIS REPENS ROOT	W06YCM9T44	ACTIB
PARSLEY	58FMD0Q0EV	ACTIB
CAPSELLA BURSA-PASTORIS	W0X9457M59	ACTIB
ARCTOSTAPHYLOS UVA-URSI LEAF	3M5V3D1X36	ACTIB
SOLIDAGO VIRGAUREA FLOWERING TOP	5405K23S50	ACTIB
BETULA PUBESCENS LEAF	84SOH0O3OO	ACTIB
EQUISETUM ARVENSE TOP	1DP6Y6B65Z	ACTIB
CYTISUS SCOPARIUS FLOWERING TOP	XZC6H8R666	ACTIB
PORK KIDNEY	X7BCI5P86H	ACTIB
COPPER	789U1901C5	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6dfce49e-b8a2-7b80-e053-2991aa0a79f9			bf43d998-18c6-4fd7-ac6a-b452fe02fbac	2018-06-06	Warnings	Exact identifier spl id: 6dfce49e-b8a2-7b80-e053-2991aa0a79f9 spl set id: bf43d998-18c6-4fd7-ac6a-b452fe02fbac

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.